Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Interactive 360-degree Videos for Teaching Gut Endoscopy to Undergraduate Medical Students

10 juillet 2026 mis à jour par: Dr Lung-Yi Mak Loey, The University of Hong Kong

Interactive 360-degree Videos for Teaching Gastrointestinal Endoscopy to Undergraduate Medical Students: a Randomized-controlled Cross-over Study

The study is a randomized-controlled cross-over study to evaluate the impact of integrating simulation-based teaching for gastrointestinal endoscopy for medical students. It will establish a novel pedagogy for teaching in a wide array of disciplines in healthcare settings. Building on an innovative virtual teaching platform, investigators will design interactive, immersive 360 virtual reality videos on Video-Vox with a facilitated structured debriefing platform in endoscopy teaching. In medical teaching, clinical exposure is indispensable to students' learning process. However, some premises are not easily accessible, such as operating theatres and endoscopy suites. By using 360 virtual reality technology, participants can be immersed in online screen-based learning in health situations that are difficult to visit in the real world.

The evident advantages of this technology will pave the way to novel approaches to medical education and training. Other real-life clinical settings, such as resuscitation scene in wards, surgical procedures in operation theatres, patient care in intensive care units, can adopt similar teaching platforms for the learner to get a 'first-hand' experience of the situation. The learning process is further reinforced by time-stamps and inquiry-based debriefing. This project will set a springboard for innovative pedagogy for undergraduate teaching in the medical curriculum.

Aperçu de l'étude

Description détaillée

The study would be conducted at the Li Ka Shing Faculty of Medicine, University of Hong Kong (HKU), Hong Kong, China. Second year students were recruited from the HKU's 6-year Bachelor of Medicine and Bachelor of Surgery (MBBS) program, with a cohort size ranging from 250-300 each year at the time this study. The first two years of this program comprise of predominately pre-clinical teaching and is followed by clinical teaching in subsequent years. GI endoscopy teaching for 2nd year students was revised in 2021 to include a lecture and on-site visit to an vacant endoscopy suite without demonstrating actual clinical procedures, to align with the Faculty's initiative for early clinical exposure.

Novice learners will be randomly divided into two groups in a 1:1 ratio. One group received simulation first, followed by conventional teaching (SIM-first); while the other received conventional teaching first, followed by simulation (CON-first). Three domains were assessed to evaluate the effectiveness of the interventions: perceived clinical competency, simulation effectiveness, and student satisfaction. These domains will be assessed after each teaching activity.

Type d'étude

Interventionnel

Inscription (Réel)

68

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Hong Kong, Chine
        • The University of Hong Kong

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • MBBS Year 2 students in the administering institution
  • voluntary participation

Exclusion Criteria:

  • none

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Autre
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation croisée
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: SIM-first
Students who receive simulation first, followed by conventional teaching
A series of 360-degree videos were produced to simulate first-hand experience of the endoscopy room. The videos aimed to replicate authentic situations for clinical decision making. Segments of actual endoscopic procedures conducted in the endoscopic suite at Queen Mary Hospital, Hong Kong, were filmed with a 360-degree camera. Additional footages were filmed with surrogate patients and healthcare professionals to demonstrate the common communication errors and pitfalls that may occur while obtaining consent and conducting the time-out process. For the post-recording editing, views showing endoluminal appearances captured during the procedure were magnified. The vital signs monitor display was highlighted to indicate clinical deterioration. The viewer can pause the video at any time and can manipulate the viewing angle to examine all directions of the endoscopy room. Guiding questions and prompts were integrated within the videos, and were configured to appear at specific time points.
Comparateur placebo: CON-first
Students who receive conventional teaching first, followed by simulation
Participants attended a 60-minute lecture that provided an overview of the different types of GI endoscopy and their indications, as well as common complications and the steps taken to minimize their occurrence.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Self-efficacy by Clinical Competence Questionnaire
Délai: Baseline, Day 2, Day 3
Clinical Competency Questionnaire (CCQ) consists of 5 items of a 10-item 5-point Likert scale (5 = strongly agree, 4 = somewhat agree, 3 = neutral, 2 = somewhat disagree, 1 = strongly disagree). For each question, the minimum score is 0, the maximum score is 5.
Baseline, Day 2, Day 3

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Simulation effectiveness
Délai: Day 2 or Day 3
The Simulation Effectiveness Tool - Modified (SET-M) is a 19-item instrument rated on a 3-point Likert scale (3 = strongly agree, 2 = somewhat agree, 1 = do not agree). For each item, the minimum score is 1, the maximum score is 3. The questionnaire comprises four subscales: pre-briefing, learning, confidence and debriefing.
Day 2 or Day 3
Student satisfaction
Délai: Day 2, Day 3
Participants will be invited to complete a short questionnaire assessing (i) their level of enjoyment and (ii) perceived improvement in knowledge acquisition and recall. These two items were rated using a 5-point Likert scale (5 = strongly agree, 4 = somewhat agree, 3 = neutral, 2 = somewhat disagree, 1 = strongly disagree). For each question, the minimum score is 1, the maximum score is 5. In addition, participants will be invited to give free-text response to identify their favorite aspect of the simulation training as well as areas of improvement.
Day 2, Day 3

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 novembre 2024

Achèvement primaire (Réel)

30 décembre 2025

Achèvement de l'étude (Réel)

30 juin 2026

Dates d'inscription aux études

Première soumission

7 juillet 2026

Première soumission répondant aux critères de contrôle qualité

10 juillet 2026

Première publication (Réel)

15 juillet 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

15 juillet 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

10 juillet 2026

Dernière vérification

1 juillet 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • TDG1013

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

De-identified individual participant data (IPD) collected in this study will be made available to other researchers upon reasonable request to the principal investigator.

Délai de partage IPD

The data will be made available upon reasonable request after publication of study data.

Critères d'accès au partage IPD

The data will be made available upon reasonable request to the principal investigator.

Type d'informations de prise en charge du partage d'IPD

  • PROTOCOLE D'ÉTUDE
  • SÈVE
  • CIF

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner